Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 28, 2020

View Archived Issues

Novel variant linked to childhood steroid-sensitive nephrotic syndrome

HanaVax, University of Tokyo present mutated Pneumococcal surface proteins

New CD73 inhibitors synthesized at Eternity Bioscience

J2H Biotech, Ahn-Gook Pharmaceutical describe new mirabegron prodrugs

University of Florida identifies new PRMT5 inhibitors

Shanghai Hansoh Biomedical, Jiangsu Hansoh Pharmaceutical patent ERK-1/2 inhibitors

Dimerix announces positive data from phase II ACTION trials of DMX-200 in kidney disease

Global phase III PolarisDMD trial of edasalonexent does not meet primary endpoint

XL-092: a promising pan-tyrosine kinase inhibitor in clinical development

First patient enrolled in the immune modulation domain of REMAP-COVID substudy

Prilenia initiates enrollment in phase III PROOF-HD trial of pridopidine

New phase I/Ib study to evaluate GEN-001 with avelumab for solid tumors

Positive 6-month interim analysis data presented from TOPAZ phase II study of SRK-015

Alzheon studies ALZ-801 in phase II biomarker study for early Alzheimer's

UKRI conditionally approves grant funding to explore SDC-1801 as treatment of COVID-19

SIMR-1281: a novel candidate for clinical trials in cancer

ASHG 2020: New inflammatory disease, and maybe, a new classification system

First-in-human data presented for TPX-0022

FDA clears IND for phase Ib study of bempegaldesleukin for COVID-19

Spero Therapeutics' SPR-720 shows promise in phase I study

Voclosporin studied for antiviral effects in kidney transplant recipients with COVID-19

Apollomics reports phase I data for APL-101

FDA approves Eysuvis for short-term treatment of dry eye disease

Valo Therapeutics describes design and preclinical results with neoantigen-coated oncolytic viruses

Novel selective TRK degraders effectively reduce TPM3-TRKA fusion protein levels

New pilot study to evaluate afamelanotide for arterial ischemic stroke

Histogen and Amerimmune collaborate to study emricasan for COVID-19

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...